Moreover, our findings demonstrate that CXCR3 promotes T-ALL cell migration, with a marked preference for CXCL10 over CXCL9 and CXCL11, suggesting selective responsiveness to a CXCL10 gradient. The gene discussed is CXCL11; the disease is acute lymphoblastic leukemia.